Published on in Vol 23, No 4 (2021): April

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/28973, first published .
People’s Willingness to Vaccinate Against COVID-19 Despite Their Safety Concerns: Twitter Poll Analysis

People’s Willingness to Vaccinate Against COVID-19 Despite Their Safety Concerns: Twitter Poll Analysis

People’s Willingness to Vaccinate Against COVID-19 Despite Their Safety Concerns: Twitter Poll Analysis

Fabian Eibensteiner   1, 2 * , MD ;   Valentin Ritschl   3, 4 * , MSc ;   Faisal A Nawaz   5 , MBBSc ;   Sajjad S Fazel   6 , MPH, PharmD ;   Christos Tsagkaris   7 , MDc ;   Stefan Tino Kulnik   8 , PhD ;   Rik Crutzen   8, 9 , PhD ;   Elisabeth Klager   2 , MSc ;   Sabine Völkl-Kernstock   2 , PhD ;   Eva Schaden   2, 10 , MD, PhD ;   Maria Kletecka-Pulker   2, 11 , PhD ;   Harald Willschke   2, 10 , MD, PhD ;   Atanas G Atanasov   2, 12, 13 , PD, PhD

1 Division of Pediatric Nephrology and Gastroenterology, Department of Pediatrics and Adolescent Medicine, Comprehensive Center for Pediatrics, Medical University of Vienna, Vienna, Austria

2 Ludwig Boltzmann Institute for Digital Health and Patient Safety, Medical University of Vienna, Vienna, Austria

3 Section for Outcomes Research, Center for Medical Statistics, Informatics, and Intelligent Systems, Medical University of Vienna, Vienna, Austria

4 Ludwig Boltzmann Institute for Arthritis and Rehabilitation, Vienna, Austria

5 College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates

6 Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada

7 Faculty of Medicine, University of Crete, Heraklion, Greece

8 Ludwig Boltzmann Institute for Digital Health and Prevention, Salzburg, Austria

9 Department of Health Promotion, Care and Public Health Research Institute, Maastricht University, Maastricht, Netherlands

10 Department of Anaesthesia, Intensive Care Medicine and Pain Medicine, Medical University of Vienna, Vienna, Austria

11 Institute for Ethics and Law in Medicine, University of Vienna, Vienna, Austria

12 Institute of Genetics and Animal Biotechnology of the Polish Academy of Sciences, Jastrzebiec, Poland

13 Department of Pharmacognosy, University of Vienna, Vienna, Austria

*these authors contributed equally

Corresponding Author:

  • Atanas G Atanasov, PD, PhD
  • Ludwig Boltzmann Institute for Digital Health and Patient Safety
  • Medical University of Vienna
  • Spitalgasse 23
  • Vienna, 1090
  • Austria
  • Phone: 43 6641929852
  • Email: Atanas.Atanasov@dhps.lbg.ac.at